- Advanced breast cancer
- Liposarcoma


EPBRIV INJECTION
MRP | : |
|
Price | : | ₹10,700.00 |
You Save | : | ₹13,400.00 (55.6%) |
1 Vial(s)
Epbriv 0.88mg Injection is a chemotherapy medication that contains eribulin as its active ingredient, classified as an antineoplastic agent. This injection is indicated for adults with advanced breast cancer or liposarcoma (a cancer that arises from adipose tissue) when other therapies have proven ineffective.
It is advised against using Epbriv 0.88mg Injection if you have a known allergy to Eribulin or any of its components. Please consult your healthcare provider if you think this may be relevant to you. This medication is not recommended for children and adolescents under 18 years of age, as the effects of Epbriv 0.88mg Injection in this demographic are not established. Prior to commencing treatment, it is essential to inform your doctor if you have a fever, infections, or any liver or heart conditions. Additionally, provide a comprehensive overview of your medical history and current medications before starting the treatment.